SCHEMBL7544189

SCHEMBL7544189

O=C1NC(=O)C(c2ccc(C(=O)O)cc2)N1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.61
ALDH1A1 P00352 2/20 0.50
MAPT P10636 1/20 0.50
LMNA P02545 1/20 0.48
GAA P10253 1/20 0.44
USP2 O75604 1/20 0.44
METAP1 P53582 1/20 0.44
TSHR P16473 3/20 0.43
TP53 P04637 2/20 0.43
DDB1 Q16531 1/20 0.42
CRBN Q96SW2 1/20 0.42
ALOX15 P16050 1/20 0.41
KDM4E B2RXH2 1/20 0.40
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13527924 0.84 TDP1 (0.80) TDP1ALDH1A1MAPTLMNAGAA
SCHEMBL8232594 0.84 TDP1 (0.59) TDP1ALDH1A1MAPTLMNAGAA
SCHEMBL497297 0.84 TDP1 (0.59) TDP1ALDH1A1MAPTLMNAGAA
SCHEMBL3635536 0.81 RARA (0.45) TDP1ALDH1A1MAPTGAAKDM4E
SCHEMBL1014744 0.79 TDP1 (0.67) TDP1ALDH1A1MAPTLMNAGAA
SCHEMBL31738422 0.79 TDP1 (0.66) TDP1ALDH1A1MAPTLMNAGAA
SCHEMBL395878 0.79 TDP1 (0.66) TDP1ALDH1A1MAPTLMNAGAA
SCHEMBL19955179 0.79 TDP1 (0.66) TDP1ALDH1A1MAPTLMNAGAA
SCHEMBL31579581 0.78 TSHR (0.46) ALDH1A1METAP1TSHRTP53DDB1
SCHEMBL7167731 0.77 TDP1 (0.69) TDP1ALDH1A1MAPTLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-213222564-U Feeding device for DL-p-hydroxyphenylhydantoin 定陶三化药业有限公司 2021-05-18 CN disclosed
EP-1210338-A2 1,4-DIAZEPINE DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO THE CENTRAL NERVOUS SYSTEM IGT Pharma Inc. (CA) 2002-06-05 EP disclosed
WO-2001010846-A2 1,4-DIAZEPINE DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO THE CENTRAL NERVOUS SYSTEM IGT PHARMA INC. (CA) 2001-02-15 WO disclosed